Showing results (511-520 of 520) with videos related to
Sort By:
Pageof 52
You have reached the last page of results.This site can display upto 520 results.
Nature Reviews. Clinical Oncology|February 9, 2019
Challenges to curing primary brain tumoursKenneth Aldape, Kevin M Brindle, Louis Chesler, et al.Cell|April 15, 2021
Glioblastomas acquire myeloid-affiliated transcriptional programs via epigenetic immunoediting to elicit immune evasionEster Gangoso, Benjamin Southgate, Leanne Bradley, et al.EMBO Molecular Medicine|March 26, 2026
CDK12/CDK13 inhibition disrupts transcriptional elongation and replication fork progression in glioblastomaSilje Lier, Sara B Markusson, Anja Kocijancic, et al.International Journal of Radiation Oncology, Biology, Physics|April 30, 2023
Framework for Quality Assurance of Ultrahigh Dose Rate Clinical Trials Investigating FLASH Effects and Current Technology GapsWei Zou, Rongxiao Zhang, Emil Schüler, et al.Neuron|September 29, 2022
Myeloid cell interferon secretion restricts Zika flavivirus infection of developing and malignant human neural progenitor cellsHarry Bulstrode, Gemma C Girdler, Tannia Gracia, et al.Science (New York, N.Y.)|February 17, 2022
From cohorts to molecules: Adverse impacts of endocrine disrupting mixturesNicolò Caporale, Michelle Leemans, Lina Birgersson, et al.Cell Stem Cell|June 18, 2019
Engineering Genetic Predisposition in Human Neuroepithelial Stem Cells Recapitulates Medulloblastoma TumorigenesisMiller Huang, Jignesh Tailor, Qiqi Zhen, et al.Genetics in Medicine Open|August 23, 2024
The challenges and opportunities of offering and integrating training in clinical molecular genetics and clinical cytogenetics: A survey of LGG Fellowship Program DirectorsJoshua L Deignan, Vimla Aggarwal, Allen E Bale, et al.Immunity|April 25, 2025
Regulatory T cell depletion promotes myeloid cell activation and glioblastoma response to anti-PD1 and tumor-targeting antibodiesFelipe Galvez-Cancino, Mariela Navarrete, Gordon Beattie, et al.Nature Communications|August 10, 2016
A protein-truncating R179X variant in RNF186 confers protection against ulcerative colitisManuel A Rivas, Daniel Graham, Patrick Sulem, et al.Pageof 52